Studies have shown the beneficial effects of long-term use, particularly with natural molecules, as they often present fewer side effects and improved safety profiles
Gastrointestinal issues top the list of concerns, but gallbladder symptoms, thyroid cancer risks, and mental health questions are all part of the evolving safety profile
Nothing about your care asks anything different of you
So what I would say to food and drink manufacturers is that these users have needs that are evolving, theyre managing tricky side-effects and it very much isnt a blanket story of decline. Dr Ahmad agrees
Key Takeaways Tirzepatide (Mounjaro) is approved for weight loss in the UK, while retatrutide is still in clinical trials and not yet available
2022;24 doi: 10.1016/j.aqrep.2022.101124